Welcome to the Radioligand Therapy Hub.
Please confirm whether you are a UK healthcare professional or a member of the public. This website is not suitable for healthcare professionals outside of the United Kingdom.
This page is intended for UK healthcare professionals and other relevant decision makers only. If you are a member of the public, please click here.
This portal is funded and owned by Novartis Pharmaceuticals UK Ltd and includes content approved by Novartis.
Adverse events reporting information can be found in the footer of this page.
